Koers Beleave Inc. Other OTC
Aandelen
BLEVF
CA0775611084
Farmaceutische producten
Omzet 2018 | - | Omzet 2019 | 2,37 2,21 | Marktkapitalisatie | 30,37 mln. 28,21 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -12 mln. -11,15 mln. | Nettowinst (verlies) 2019 | -33 mln. -30,65 mln. | EV/omzet 2018 | - |
Nettoliquiditeiten 2018 | 5,2 mln. 4,83 mln. | Nettoschuld 2019 | 10,32 mln. 9,58 mln. | EV/omzet 2019 | 17.137.012 x |
K/w-verhouding 2018 |
-4,72
x | K/w-verhouding 2019 |
-0,76
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 98,39% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 26-05-00 | |
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-15 |
Kevin Keagan
BRD | Director/Board Member | - | 24-10-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-15 |
Founder | - | 26-05-00 | |
Kevin Keagan
BRD | Director/Board Member | - | 24-10-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+39,33% | 6,11 mld. | |
-18,38% | 4,35 mld. | |
-9,17% | 3,19 mld. | |
+3,98% | 3,15 mld. | |
-3,41% | 2,51 mld. | |
+48,74% | 1,98 mld. | |
-4,82% | 1,74 mld. | |
-1,24% | 1,63 mld. | |
-8,96% | 1,6 mld. |